awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35079519-129ABE5E-84F7-4BEA-88BF-DDAD522099E7
Q35079519-129ABE5E-84F7-4BEA-88BF-DDAD522099E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35079519-129ABE5E-84F7-4BEA-88BF-DDAD522099E7
Bleeding avoidance strategies. Consensus and controversy
P2860
Q35079519-129ABE5E-84F7-4BEA-88BF-DDAD522099E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35079519-129ABE5E-84F7-4BEA-88BF-DDAD522099E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1078f8fdc8efc0496a9f1d36634094922cb18c3a
P2860
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial.